Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist.  The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am.   Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases.  SAM has strategic collaborations with public and private institutions for research and clinical work.  SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi

Mencast Holdings Ltd.

Mencast Holdings Ltd is offering 22.5m new shares priced at 28 cents per share of which 1.5m shares will be offer via public and the remaining through a private placement. The Company manufacture and supply sterngear equipment and provide sterngear services for a wide range of commercial vessel-applications.

Revenue increased from S$11.65m in FY05 to S$18.8m in FY07 but net profit improved from S$707k to S$4.8m in FY07 indicating a strong improvement in net margin from 6.1% to 25.5% over the last 3 years.

Based on the IPO price, the market cap is S$41.3m. An ultra small cap company on Catalist. The EPS for FY2007 bsaed on post-invitation shares of 147.5m is 3.27 cents. The Company sold itself at a valuation of S$24m to pre-ipo investors on 30 May 2008 (or 19 cents per share), it is amazing that within a short span of less than one month, it can repackaged itself to sell to the market at 28 cents per share at a significantly higher valuation. The identity of the pre-ipo investor was not disclosed as it holds less than 5% and is not selling any vendor share. Personally, i dont like such 'restructuring' within a short span of time. There are several possible reasons for doing this pre-ipo transaction - (1) Owners want to cash out but didnt want to sell vendor at IPO for fear of depressing the market; (2) Underwriters want to find some strong hands to anchor this IPO but anchor will only come in a lower price as he/she will be subject to 6 months moratorium. (3) Special arrangement with underwriters, etc. I have no idea what the reasons are but certainly never like this kind of 'restructuring' as i am not the one who benefited from it but i would have preferred if the identity of the pre-ipo investor was disclosed. :P

It also seemed amazing to me that the margins can improve so strongly over the last 3 years and personally, I would like to adopt a 'wait-and-see' attitude on the sustainability of this margins in the next few quarters. I would rate this a 1 chilli counter and observe this company for a longer while.

Comments